Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.23 [0.09-0.57],0.0017222912999956,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.16 [1.06-1.28],0.00182237306126402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CTRB1,Chymotrypsinogen B,Inverse variance weighted,27,0.9 [0.84-0.97],0.00300313437630895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,20,1.1 [1.03-1.16],0.00320151437439713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.34 [0.16-0.71],0.00455839077715565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.41 [1.11-1.78],0.00466413766664509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.33 [0.15-0.71],0.00490135054233798,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.84 [0.75-0.95],0.00616365052401703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCG2,Secretogranin-2,Wald ratio,1,0.33 [0.15-0.73],0.00665731120059903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1.19 [1.05-1.35],0.00707504264636201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.27 [1.07-1.5],0.00712483155534749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,APOA4,Apolipoprotein A-IV,Wald ratio,1,0.32 [0.14-0.74],0.00758443800649675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,0.89 [0.82-0.97],0.00820328213106952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1.12 [1.03-1.22],0.00857271946121935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.9 [0.82-0.97],0.00956392605648201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.81 [0.68-0.95],0.0116133892231319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.59 [1.11-2.27],0.0117884589631168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.67 [0.48-0.92],0.0139191649364491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.87 [0.77-0.97],0.0142669712847525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.47 [0.26-0.87],0.0160027812529496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.19 [1.03-1.37],0.0164563505033333,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.22 [1.03-1.44],0.0182824655336748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DRAXIN,Draxin,Inverse variance weighted,13,1.1 [1.01-1.19],0.0201413080181952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,1.4 [1.05-1.86],0.0223751770649043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.09 [1.01-1.17],0.0225637704812111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.51 [0.28-0.92],0.0245730997091871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.56 [1.04-2.33],0.0321430416049582,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,0.78 [0.62-0.98],0.0334832702440979,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LGALS9,Galectin-9,Inverse variance weighted,26,1.09 [1-1.18],0.0376344514683793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.86 [0.75-0.99],0.0386401351506199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDH15,Cadherin-15,Inverse variance weighted,18,0.91 [0.83-1],0.0424600552159351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.83 [0.69-0.99],0.0427335005721459,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.14 [1-1.29],0.0476650658746437,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.23 [1-1.51],0.0478273918310179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.93 [0.87-1],0.0494443799125475,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,0.82 [0.67-1],0.0554757980996265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.91 [0.83-1.01],0.0636594648039757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.1 [0.99-1.21],0.0638933257866164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NRP2,Neuropilin-2,Inverse variance weighted,11,0.89 [0.78-1.01],0.0650890024576082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VCAN,Versican core protein,Inverse variance weighted,31,0.94 [0.87-1],0.0672791225625463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,0.93 [0.86-1.01],0.0702353425099637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.11 [0.99-1.23],0.0729187896238349,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.89 [0.78-1.01],0.0758127642294982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.05 [0.99-1.11],0.0776846507515259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,0.93 [0.86-1.01],0.0777271875283457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LGALS4,Galectin-4,Inverse variance weighted,4,1.27 [0.97-1.66],0.0788644083650776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.91 [0.82-1.01],0.0845926472586395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CTSL,Cathepsin L1,Wald ratio,1,2.07 [0.9-4.76],0.0849250737132394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.12 [0.98-1.27],0.0861788234590113,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VIT,Vitrin,Inverse variance weighted,25,0.95 [0.9-1.01],0.0883736653297121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.19 [0.97-1.45],0.0931131246780107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.94 [0.86-1.01],0.0958833935240546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.03 [0.99-1.07],0.0967345540923183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.88 [0.75-1.02],0.0971842360427869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,0.82 [0.66-1.04],0.0976159282224581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SDC1,Syndecan-1,Inverse variance weighted,2,1.26 [0.96-1.66],0.0976562714191901,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.12 [0.98-1.27],0.0992142446173207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.05 [0.99-1.11],0.0992889138122815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,0.83 [0.67-1.03],0.0992983596738201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.19 [0.97-1.45],0.100296421891784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPON1,Spondin-1,Inverse variance weighted,21,1.08 [0.98-1.19],0.101350914235524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LCN15,Lipocalin-15,Inverse variance weighted,20,1.06 [0.99-1.13],0.104138730223158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VWC2,Brorin,Inverse variance weighted,22,1.09 [0.98-1.22],0.106228416073281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AREG,Amphiregulin,Inverse variance weighted,3,0.82 [0.64-1.05],0.109308110011986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,16,0.91 [0.81-1.02],0.109581725202112,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,0.89 [0.76-1.03],0.113981494310619,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.05 [0.99-1.13],0.114691066459302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,1.28 [0.94-1.73],0.118048370665573,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,0.89 [0.78-1.03],0.119203241937053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,1.07 [0.98-1.15],0.120326852622941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.08 [0.98-1.18],0.127744953949302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.93 [0.85-1.02],0.131571021078263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.11 [0.97-1.28],0.133536537533549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.93 [0.84-1.02],0.135763881660003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.92 [0.83-1.03],0.13969460426552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SBSN,Suprabasin,Inverse variance weighted,17,0.95 [0.89-1.02],0.140761768627411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.79 [0.8-3.98],0.154325273769182,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PALM2,Paralemmin-2,Inverse variance weighted,8,1.12 [0.96-1.3],0.159130094934767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.81 [0.61-1.08],0.16057259653952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.15 [0.95-1.4],0.161260737759572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.21 [0.93-1.57],0.161590382538905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL19,Interleukin-19,Inverse variance weighted,11,1.08 [0.97-1.21],0.171106206023177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AGRN,Agrin,Inverse variance weighted,17,0.92 [0.82-1.04],0.175308601925753,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.96 [0.91-1.02],0.176296921017294,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.16 [0.94-1.43],0.177290307326784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,1.04 [0.98-1.1],0.183607296132365,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.93 [0.84-1.04],0.185943209538792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.95 [0.89-1.02],0.186147072454285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDH1,Cadherin-1,Wald ratio,1,0.58 [0.25-1.31],0.190446235401931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REN,Renin,Inverse variance weighted,4,1.09 [0.95-1.25],0.198596856109366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.07 [0.96-1.19],0.198630052480877,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.93 [0.83-1.04],0.198906807965694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,XCL1,Lymphotactin,Inverse variance weighted,31,0.96 [0.9-1.02],0.201806885196867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Inverse variance weighted,6,0.89 [0.74-1.07],0.202592905492252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CALB2,Calretinin,Wald ratio,1,1.5 [0.8-2.78],0.20406242781088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.27 [0.88-1.83],0.205986752869493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.78 [0.54-1.14],0.207203011453362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,0.96 [0.89-1.03],0.208647022050646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.85 [0.65-1.1],0.211476885003248,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,3,0.8 [0.56-1.14],0.212327991298127,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLK6,Kallikrein-6,Inverse variance weighted,4,1.13 [0.93-1.36],0.215187372412795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,1.03 [0.98-1.08],0.215499114139662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.94 [0.86-1.03],0.215693777816369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.2 [0.9-1.61],0.216276045376717,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.91 [0.78-1.06],0.216416315523113,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.15 [0.92-1.45],0.217494534035336,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.86 [0.67-1.1],0.219939540892707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.94 [0.84-1.04],0.222017923407739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.73 [0.44-1.21],0.226027206368526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PI3,Elafin,Inverse variance weighted,10,1.07 [0.96-1.2],0.231683226273503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.94 [0.85-1.04],0.237145155491397,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDHR1,Cadherin-related family member 1,Inverse variance weighted,9,1.06 [0.96-1.16],0.237738054000292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.87 [0.69-1.1],0.240631854999721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.89 [0.73-1.08],0.243900995828648,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.95 [0.86-1.04],0.243946724918327,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.1 [0.94-1.29],0.247532511344029,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPRR3,Small proline-rich protein 3,Inverse variance weighted,11,1.08 [0.95-1.24],0.248178526222634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ANXA5,Annexin A5,Inverse variance weighted,2,1.29 [0.83-2.01],0.249225688165063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDH3,Cadherin-3,Inverse variance weighted,2,1.29 [0.83-2.02],0.254494843444424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CST6,Cystatin-M,Inverse variance weighted,2,1.12 [0.92-1.35],0.255094275068216,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.94 [0.84-1.05],0.256117853127131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PALM,Paralemmin-1,Inverse variance weighted,6,0.9 [0.74-1.08],0.256502580334564,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD46,Membrane cofactor protein,Wald ratio,1,0.78 [0.51-1.2],0.260186257573945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.07 [0.95-1.19],0.262865418752427,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,9,0.93 [0.82-1.06],0.268662498339299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.3 [0.81-2.07],0.273969589448601,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NPPC,C-type natriuretic peptide,Wald ratio,1,1.67 [0.67-4.17],0.274272804520248,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RGMB,RGM domain family member B,Inverse variance weighted,9,0.91 [0.78-1.07],0.274652869601483,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.15 [0.9-1.46],0.275775796797758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.91 [0.76-1.08],0.275852567023695,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,1.06 [0.96-1.17],0.276227343639566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,7,1.15 [0.89-1.48],0.28423552192533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,2,1.22 [0.85-1.75],0.288058485802399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,1.06 [0.95-1.17],0.28946146765909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.86 [0.64-1.14],0.294504268369841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.85 [0.62-1.16],0.299176249189569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NEO1,Neogenin,Wald ratio,1,0.77 [0.46-1.27],0.301786240453365,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,0.92 [0.79-1.08],0.311207084247145,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DLK1,Protein delta homolog 1,Inverse variance weighted,25,1.04 [0.97-1.11],0.311393163807494,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.96 [0.9-1.03],0.311726443695262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,THBD,Thrombomodulin,Inverse variance weighted,5,1.1 [0.91-1.32],0.315641898380918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.14 [0.88-1.49],0.321561482045806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FAM3D,Protein FAM3D,Inverse variance weighted,17,1.08 [0.93-1.24],0.322136616764603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.82 [0.56-1.22],0.326569384609185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.92 [0.78-1.09],0.331719249404166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.67 [0.59-4.74],0.331909521524485,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,0.97 [0.91-1.03],0.333819630684885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,21,0.98 [0.95-1.02],0.335388182620952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RBP2,Retinol-binding protein 2,Wald ratio,1,0.74 [0.39-1.38],0.339229775585185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RETN,Resistin,Inverse variance weighted,9,0.96 [0.89-1.04],0.33956620996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.92 [0.78-1.09],0.343889746493704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.97 [0.91-1.03],0.346650570237598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,0.98 [0.93-1.03],0.348354906933944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD83,CD83 antigen,Inverse variance weighted,5,0.89 [0.69-1.14],0.350012686957629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.86 [0.63-1.18],0.350954593434851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,0.96 [0.88-1.05],0.352043419467159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COLEC12,Collectin-12,Inverse variance weighted,11,0.93 [0.81-1.08],0.352188649867312,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLK11,Kallikrein-11,Inverse variance weighted,6,0.96 [0.89-1.04],0.353629933365031,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.09 [0.91-1.32],0.355100033961592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PRSS8,Prostasin,Inverse variance weighted,5,0.88 [0.67-1.15],0.355126506144305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PSAP,Prosaposin,Inverse variance weighted,5,1.09 [0.91-1.31],0.356978170891629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.9 [0.71-1.13],0.359515002353018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,6,0.92 [0.78-1.1],0.359754036480437,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VASN,Vasorin,Inverse variance weighted,14,1.03 [0.96-1.11],0.360986821149404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.04 [0.96-1.12],0.362670985500562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1.05 [0.94-1.18],0.363454477237151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.93 [0.8-1.08],0.366416315273879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.03 [0.97-1.08],0.373134625038587,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DSG3,Desmoglein-3,Inverse variance weighted,7,1.07 [0.93-1.22],0.375652895671496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,6,1.08 [0.91-1.29],0.376515741715068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PENK,Proenkephalin-A,Inverse variance weighted,19,1.05 [0.94-1.17],0.376956484479957,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.3 [0.72-2.35],0.377237109708075,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LMNB2,Lamin-B2,Wald ratio,1,0.66 [0.25-1.69],0.381031866589334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEPTIN8,Septin-8,Inverse variance weighted,2,0.75 [0.39-1.43],0.381843090444348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CFD,Complement factor D,Inverse variance weighted,11,0.95 [0.84-1.07],0.385015853236471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.89 [0.68-1.16],0.385163109218703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,14,1.05 [0.94-1.17],0.388518202324658,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDH6,Cadherin-6,Inverse variance weighted,29,1.03 [0.96-1.1],0.393757227349149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MMP10,Stromelysin-2,Inverse variance weighted,22,1.04 [0.95-1.14],0.394327471186196,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,21,0.96 [0.88-1.05],0.395478623628644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCN5,CCN family member 5,Inverse variance weighted,8,0.88 [0.65-1.18],0.397342036884867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.93 [0.79-1.1],0.401030753550266,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLK4,Kallikrein-4,Inverse variance weighted,17,1.04 [0.95-1.13],0.405955233310267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD160,CD160 antigen,Inverse variance weighted,11,0.96 [0.87-1.06],0.406600956997846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1.07 [0.91-1.24],0.413336749312362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1.1 [0.87-1.39],0.416651690565438,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.93 [0.79-1.1],0.417006229726838,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.96 [0.86-1.07],0.422109142063155,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.05 [0.93-1.18],0.423150842196118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.95 [0.84-1.08],0.432417763960771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RTBDN,Retbindin,Inverse variance weighted,3,0.87 [0.62-1.23],0.440513676730968,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.03 [0.95-1.12],0.444572030782503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,14,1.04 [0.95-1.13],0.444953387501626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CTSV,Cathepsin L2,Inverse variance weighted,11,0.95 [0.83-1.09],0.445101803960747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,14,0.97 [0.89-1.05],0.44711728966172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCN4,CCN family member 4,Inverse variance weighted,27,1.03 [0.96-1.1],0.456043976972317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL15,Interleukin-15,Wald ratio,1,3.74 [0.11-123.1],0.458753127671672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CALB1,Calbindin,Inverse variance weighted,2,0.85 [0.54-1.32],0.459269855752184,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.02 [0.97-1.06],0.460446183252246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.91 [0.71-1.17],0.464434704275028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RGMA,Repulsive guidance molecule A,Inverse variance weighted,12,0.96 [0.87-1.07],0.468704549999919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,11,1.06 [0.9-1.25],0.471775063527516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NECTIN4,Nectin-4,Inverse variance weighted,7,1.04 [0.93-1.17],0.472427560431588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.03 [0.95-1.11],0.473903637173672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.93 [0.75-1.14],0.474989239348913,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.87 [0.59-1.28],0.4768358751273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPON2,Spondin-2,Inverse variance weighted,4,1.06 [0.9-1.25],0.476964221436178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.06 [0.9-1.24],0.477579887050504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NECTIN2,Nectin-2,Inverse variance weighted,5,0.96 [0.86-1.07],0.479482907342682,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,0.88 [0.61-1.26],0.485284780806595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.96 [0.86-1.07],0.486862433105977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BSG,Basigin,Wald ratio,1,0.91 [0.69-1.2],0.49375772997054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AMBP,Protein AMBP,Inverse variance weighted,3,1.09 [0.85-1.41],0.496972118188797,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.95 [0.82-1.1],0.499684380975168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD7,T-cell antigen CD7,Inverse variance weighted,8,0.97 [0.9-1.05],0.500589849145093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.12 [0.8-1.56],0.504348423364448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PRSS2,Trypsin-2,Inverse variance weighted,3,1.09 [0.85-1.39],0.506855327353554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1.03 [0.94-1.12],0.506989265147196,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.04 [0.92-1.18],0.508642462741698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AGRP,Agouti-related protein,Inverse variance weighted,3,1.19 [0.71-1.99],0.510932319580558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.02 [0.96-1.09],0.512525326320489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,1.08 [0.86-1.36],0.515398942057443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.16 [0.73-1.85],0.519555772644257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.94 [0.79-1.13],0.520415046472117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.2 [0.68-2.12],0.52639206428888,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.14 [0.75-1.73],0.530734686573413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,0.92 [0.7-1.2],0.532908938475118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CX3CL1,Fractalkine,Inverse variance weighted,9,0.95 [0.79-1.13],0.535170743455431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MB,Myoglobin,Wald ratio,1,1.38 [0.5-3.8],0.535689963149143,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,1.05 [0.89-1.24],0.535961939777282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.09 [0.84-1.41],0.537179083245688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,22,0.97 [0.88-1.07],0.538258765475577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.02 [0.96-1.09],0.539542559403852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.04 [0.91-1.2],0.544325250758731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.97 [0.88-1.07],0.54464403729015,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.88 [0.58-1.34],0.549724372610531,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.9 [0.63-1.28],0.551338108430296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CALCA,Calcitonin,Inverse variance weighted,5,1.13 [0.75-1.69],0.555151007148752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.93 [0.73-1.18],0.556773609307586,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.05 [0.89-1.24],0.563141050160454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,0.98 [0.92-1.05],0.563801422563052,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.08 [0.84-1.38],0.564522563010847,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PLA2G1B,Phospholipase A2,Wald ratio,1,0.82 [0.43-1.59],0.565418867757513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.29 [0.54-3.12],0.568576507459007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,0.97 [0.88-1.07],0.569484940914384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,1.05 [0.89-1.23],0.572228580016431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,UMOD,Uromodulin,Inverse variance weighted,29,1.01 [0.97-1.06],0.573323398150207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,1.08 [0.83-1.4],0.574113989527649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BGLAP,Osteocalcin,Inverse variance weighted,2,1.17 [0.68-2.01],0.5743459963268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,0.82 [0.41-1.65],0.574408447269997,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.14 [0.72-1.79],0.579383525590868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.02 [0.96-1.07],0.583375675279705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.03 [0.93-1.14],0.584852640934265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.98 [0.91-1.06],0.586756264498115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHGA,Chromogranin-A,Inverse variance weighted,3,0.95 [0.78-1.15],0.591657689936063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,10,1.03 [0.92-1.16],0.59344709393442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.97 [0.86-1.09],0.596305456191605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.07 [0.83-1.39],0.599456792800647,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,OGN,Mimecan,Inverse variance weighted,30,0.97 [0.88-1.08],0.600852349032879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.98 [0.92-1.05],0.602051048018986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DPT,Dermatopontin,Inverse variance weighted,21,1.03 [0.93-1.14],0.602878180297418,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.1 [0.77-1.57],0.603506968786735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ALCAM,CD166 antigen,Inverse variance weighted,6,1.07 [0.84-1.35],0.604990195952896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LAYN,Layilin,Inverse variance weighted,20,1.03 [0.92-1.15],0.606382047480773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.33 [0.45-3.96],0.60775995448094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Inverse variance weighted,2,1.16 [0.65-2.06],0.61362636327993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CST3,Cystatin-C,Inverse variance weighted,10,1.03 [0.92-1.16],0.617777734430132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.85 [0.45-1.6],0.618899414403064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LGALS1,Galectin-1,Inverse variance weighted,6,0.97 [0.87-1.09],0.624876920306957,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.09 [0.77-1.54],0.626344609581661,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,0.95 [0.79-1.16],0.631402259896586,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COL1A1,Collagen alpha-1(I) chain,Wald ratio,1,1.23 [0.53-2.83],0.63167791133122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.97 [0.87-1.09],0.634542538241486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.04 [0.88-1.24],0.634828360270181,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.02 [0.94-1.11],0.640853914653694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.09 [0.76-1.56],0.642243207537237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FBLN2,Fibulin-2,Inverse variance weighted,11,0.98 [0.88-1.08],0.643140638742649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GPC1,Glypican-1,Inverse variance weighted,17,0.98 [0.88-1.08],0.644022817947935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.8 [0.31-2.07],0.644335610840118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD27,CD27 antigen,Inverse variance weighted,9,0.97 [0.87-1.09],0.645005956199378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NXPH3,Neurexophilin-3,Inverse variance weighted,11,0.97 [0.86-1.1],0.647826042289056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MMP3,Stromelysin-1,Inverse variance weighted,34,1.02 [0.94-1.11],0.647899546524658,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,0.98 [0.89-1.08],0.651076855205983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD302,CD302 antigen,Inverse variance weighted,9,0.97 [0.85-1.1],0.656393999948283,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NRP1,Neuropilin-1,Inverse variance weighted,12,0.98 [0.88-1.09],0.659704847811435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,0.94 [0.72-1.23],0.662290483096023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.09 [0.75-1.57],0.662843402996322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,0.99 [0.93-1.05],0.663389441310677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.03 [0.91-1.17],0.664616609866301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.99 [0.93-1.05],0.669513529483673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.93 [0.67-1.29],0.671183275499889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,4,1.09 [0.73-1.62],0.671801233855772,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1.01 [0.95-1.08],0.671815208296362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.97 [0.86-1.11],0.673145693222872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCN3,CCN family member 3,Inverse variance weighted,19,1.03 [0.91-1.15],0.676271507545094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.93 [0.67-1.3],0.680985064294525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.99 [0.92-1.05],0.683356734758516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,APOA2,Apolipoprotein A-II,Wald ratio,1,0.89 [0.5-1.58],0.683666470526828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.97 [0.85-1.12],0.685218311512696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.02 [0.92-1.14],0.685285434165183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.96 [0.77-1.18],0.6854737824157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.94 [0.71-1.25],0.686054069447855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EDN1,Endothelin-1,Inverse variance weighted,3,1.06 [0.81-1.37],0.686627351729639,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PGA4,Pepsin A-4,Inverse variance weighted,2,1.14 [0.59-2.23],0.691519417029896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.98 [0.89-1.08],0.693495997487297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.19 [0.5-2.86],0.693801223563131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.97 [0.84-1.12],0.694733937071326,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.05 [0.82-1.35],0.698714989184577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,1.01 [0.94-1.09],0.706098714636188,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.02 [0.93-1.11],0.708571883142349,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.94 [0.66-1.33],0.710717395419417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.17 [0.51-2.65],0.711437160733708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.91 [0.54-1.51],0.712688625731008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,1.11 [0.65-1.89],0.715267838271553,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.94 [0.67-1.32],0.715611245023589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.97 [0.84-1.12],0.715718542317773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.92 [0.61-1.41],0.717329539461373,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.99 [0.91-1.06],0.71799061762707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CSTB,Cystatin-B,Inverse variance weighted,28,1.01 [0.94-1.09],0.719583133682776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLK8,Kallikrein-8,Inverse variance weighted,12,1.02 [0.92-1.14],0.72307646523199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.98 [0.86-1.11],0.726524303912437,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.02 [0.9-1.17],0.727550861259854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,0.92 [0.55-1.53],0.734959695123328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.02 [0.89-1.18],0.735923366561402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.03 [0.86-1.23],0.736052834389421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.99 [0.94-1.04],0.73795044247588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.93 [0.6-1.44],0.7419147997169,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.94 [0.67-1.32],0.741940590624517,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,1.04 [0.82-1.32],0.742285593654847,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LGALS3,Galectin-3,Inverse variance weighted,25,1.01 [0.93-1.1],0.742328539340233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,1.09 [0.65-1.84],0.743501936781318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,1.06 [0.76-1.48],0.743597221002855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.05 [0.78-1.42],0.743902686569092,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PRELP,Prolargin,Inverse variance weighted,9,1.02 [0.9-1.15],0.745124598344411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,0.99 [0.91-1.07],0.749004832139654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ANG,Angiogenin,Inverse variance weighted,19,1.01 [0.93-1.1],0.751620368281226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.98 [0.87-1.11],0.756411640147125,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCGB1A1,Uteroglobin,Inverse variance weighted,12,1.02 [0.9-1.16],0.756665639229927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MMP7,Matrilysin,Inverse variance weighted,13,1.02 [0.92-1.12],0.770211140540199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.96 [0.73-1.26],0.772093110564734,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,1.01 [0.96-1.05],0.784998987186351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PCDHB15,Protocadherin beta-15,Inverse variance weighted,29,0.99 [0.94-1.05],0.785135458733184,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DSG2,Desmoglein-2,Inverse variance weighted,11,0.98 [0.87-1.11],0.788697478291279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,21,1.01 [0.92-1.12],0.78911325673076,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,12,0.98 [0.84-1.14],0.79191415041955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,0.98 [0.85-1.13],0.792285172670919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,0.98 [0.86-1.13],0.793488668436898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,0.95 [0.67-1.35],0.793781156315925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.04 [0.8-1.35],0.79710718018827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1.08 [0.58-2.02],0.806053980592761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPARCL1,SPARC-like protein 1,Inverse variance weighted,35,0.99 [0.93-1.06],0.807080248440815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.11 [0.48-2.52],0.811118688081695,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,0.99 [0.9-1.08],0.811762086554675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.93 [0.51-1.69],0.812015686575311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.99 [0.9-1.09],0.81308524204429,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.97 [0.76-1.24],0.816170270736966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GRN,Progranulin,Inverse variance weighted,7,0.98 [0.83-1.15],0.818647591334237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.96 [0.7-1.33],0.819996755240892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SERPINB8,Serpin B8,Inverse variance weighted,28,1.01 [0.96-1.05],0.820285091362043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DSC2,Desmocollin-2,Inverse variance weighted,9,0.99 [0.87-1.12],0.820913710950875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,0.96 [0.65-1.4],0.821447514833641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RSPO1,R-spondin-1,Inverse variance weighted,5,1.03 [0.78-1.36],0.825696788651419,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,0.91 [0.37-2.2],0.829082679469665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.01 [0.91-1.12],0.829231418932156,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.01 [0.91-1.13],0.82969410088505,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.01 [0.94-1.09],0.835528510550755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.01 [0.94-1.07],0.838641542245047,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,5,1.03 [0.77-1.39],0.842265482135488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.99 [0.88-1.11],0.846684262684948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.01 [0.92-1.11],0.85457938087272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KITLG,Kit ligand,Wald ratio,1,1.07 [0.51-2.27],0.855346446136003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,OCLN,Occludin,Inverse variance weighted,2,0.97 [0.73-1.3],0.857519245783928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1 [0.95-1.05],0.861713296578793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.02 [0.79-1.32],0.869033397000881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GUCA2A,Guanylin,Inverse variance weighted,9,0.99 [0.83-1.17],0.870797887656111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MMP13,Collagenase 3,Inverse variance weighted,2,0.92 [0.31-2.66],0.871419910589738,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1 [0.96-1.05],0.87301237439833,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1.01 [0.88-1.16],0.88067503161025,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.01 [0.93-1.08],0.883425807812211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.02 [0.83-1.25],0.883915701970159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,22,0.99 [0.93-1.07],0.887559002660895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PCDH12,Protocadherin-12,Inverse variance weighted,13,1.01 [0.92-1.11],0.888100327968673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPP1,Osteopontin,Inverse variance weighted,8,1.02 [0.77-1.35],0.889101212601642,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL17C,Interleukin-17C,Inverse variance weighted,3,0.97 [0.6-1.57],0.890621200792618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,1.03 [0.65-1.64],0.896575810106259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.01 [0.81-1.26],0.899645732351849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.01 [0.86-1.19],0.901444388234416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1 [0.94-1.06],0.902780293094592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RSPO3,R-spondin-3,Inverse variance weighted,6,0.98 [0.77-1.26],0.90280318695426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.01 [0.9-1.13],0.90456396229199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VGF,Neurosecretory protein VGF,Wald ratio,1,0.94 [0.33-2.67],0.905875154351495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.97 [0.62-1.54],0.906973856621395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,1 [0.96-1.04],0.907391249722808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Wald ratio,1,1.01 [0.89-1.14],0.91621655269394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHGB,Secretogranin-1,Inverse variance weighted,27,1 [0.93-1.07],0.922920006881109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1 [0.91-1.11],0.927546559282793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.01 [0.78-1.31],0.930561618954717,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1 [0.9-1.1],0.93181086305474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.01 [0.79-1.3],0.932192252309527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.99 [0.8-1.23],0.932941402708455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,1 [0.94-1.07],0.938745636776473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.01 [0.71-1.44],0.941164421031467,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1 [0.93-1.07],0.944422951960309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,1.01 [0.67-1.53],0.94462409972717,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GPR158,Probable G-protein coupled receptor 158,Wald ratio,1,0.98 [0.54-1.79],0.945365701556174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1 [0.94-1.06],0.946020987930804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,24,1 [0.94-1.06],0.948791520633975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,F3,Tissue factor,Inverse variance weighted,11,1 [0.87-1.16],0.953719002119787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.99 [0.75-1.32],0.959460701372415,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1 [0.95-1.05],0.960408951123108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,1 [0.92-1.09],0.961321212908325,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,0.99 [0.76-1.3],0.963263753655899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHAD,Chondroadherin,Inverse variance weighted,3,1 [0.89-1.13],0.964000282276935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1 [0.86-1.16],0.964906337774328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1 [0.86-1.16],0.979919945778397,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.01 [0.51-2.01],0.980830026732446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1 [0.77-1.29],0.982972012677769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.99 [0.4-2.44],0.98320239471285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP6,Gastrotropin,Wald ratio,1,1 [0.75-1.33],0.986640840948506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,UNC5D,Netrin receptor UNC5D,Wald ratio,1,0.99 [0.04-23.05],0.993197752984209,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1 [0.77-1.3],0.995247224403005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1 [0.95-1.05],0.997116177193472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1 [0.37-2.69],0.997171275754978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PGF,Placenta growth factor,Inverse variance weighted,2,1 [0.38-2.65],0.998610914859402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.63 [0.5-0.81],0.00026906971564361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PGF,Placenta growth factor,Inverse variance weighted,5,0.63 [0.47-0.86],0.00325848719667969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.35 [1.1-1.66],0.0035979181554461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.33 [0.15-0.71],0.00490135054233798,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1.11 [1.03-1.19],0.00562816403902848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,0.91 [0.84-0.98],0.0110053107908031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,1.06 [1.01-1.11],0.0129733925144275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LGALS9,Galectin-9,Inverse variance weighted,36,1.1 [1.02-1.19],0.0157823452317715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KITLG,Kit ligand,Inverse variance weighted,30,1.19 [1.03-1.37],0.0188985366859601,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.67 [0.48-0.94],0.021047034515768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,24,0.83 [0.7-0.97],0.0216309796106096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.73 [0.56-0.96],0.0250018003622139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,0.81 [0.67-0.98],0.0267049107774413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.2 [1.02-1.41],0.0277529345248341,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CST6,Cystatin-M,Inverse variance weighted,26,1.19 [1.02-1.4],0.0299877004987591,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COL1A1,Collagen alpha-1(I) chain,Inverse variance weighted,16,0.82 [0.69-0.98],0.0326832156367024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.8 [0.65-0.98],0.0345519818840876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1.14 [1.01-1.29],0.035968390481702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.6 [0.37-0.98],0.0398784910459269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LCN15,Lipocalin-15,Inverse variance weighted,22,1.07 [1-1.13],0.0484159703992528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,0.39 [0.15-1.02],0.0553152408437714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AGRN,Agrin,Inverse variance weighted,14,0.78 [0.6-1.01],0.0555358240176294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.63 [0.39-1.01],0.0555877597846018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PSAP,Prosaposin,Inverse variance weighted,13,1.13 [1-1.28],0.0598146748928852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,17,0.85 [0.71-1.01],0.0600026901192765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,UMOD,Uromodulin,Inverse variance weighted,34,1.13 [0.99-1.28],0.061002950990932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.64 [0.97-2.79],0.0650365986230353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.09 [0.99-1.19],0.0655791472057779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.42 [0.98-2.06],0.0668181484141399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.72 [0.5-1.03],0.0723752609347048,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.83 [0.67-1.02],0.075893727531109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.94 [0.88-1.01],0.0761736371839237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.31 [0.96-1.78],0.08523500210379,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,22,1.14 [0.98-1.33],0.0866766968487597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.84 [0.68-1.03],0.0872447860908752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LMNB2,Lamin-B2,Inverse variance weighted,8,1.28 [0.96-1.7],0.0893466854686195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.13 [0.98-1.31],0.091691593149408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.22 [0.97-1.53],0.0930276784160293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.17 [0.97-1.42],0.0937652529213701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,6,0.71 [0.47-1.06],0.0941443783652292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,1.26 [0.95-1.67],0.108135375882685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,0.79 [0.6-1.05],0.108847060271565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.77 [0.55-1.06],0.109745122662997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.11 [0.98-1.26],0.110511225369569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.63 [0.36-1.12],0.113937953542018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,2.16 [0.83-5.63],0.11419091506724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PCDHB15,Protocadherin beta-15,Inverse variance weighted,19,0.91 [0.82-1.02],0.118306086660225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.84 [0.67-1.05],0.119117902436919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.69 [0.43-1.1],0.120174589020558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.51 [0.22-1.19],0.120285453804241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.77 [0.55-1.07],0.121878135488828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.93 [0.85-1.02],0.125519250521733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,2.06 [0.81-5.2],0.127380589205543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.25 [0.94-1.66],0.128522760443626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Inverse variance weighted,20,1.14 [0.96-1.35],0.13117706508385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.93 [0.85-1.02],0.136428680139271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.49 [0.88-2.54],0.137528631550083,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,1.16 [0.95-1.42],0.138216423107616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RSPO1,R-spondin-1,Inverse variance weighted,8,0.85 [0.68-1.05],0.138595371397239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,1.7 [0.84-3.45],0.140785763744212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.91 [0.8-1.03],0.140943221916991,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.75 [0.52-1.1],0.143726342731848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDH6,Cadherin-6,Inverse variance weighted,5,1.41 [0.89-2.22],0.144251939205374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,0.89 [0.76-1.04],0.145172323401026,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.78 [0.56-1.09],0.147146360493261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.82 [0.63-1.07],0.147264813998198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.24 [0.93-1.66],0.149360077847634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.88 [0.73-1.05],0.150066298747548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.07 [0.98-1.17],0.151274157785867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VWC2,Brorin,Inverse variance weighted,12,1.24 [0.92-1.66],0.152570479037211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,1.44 [0.87-2.37],0.153464417303527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BGLAP,Osteocalcin,Inverse variance weighted,8,0.82 [0.62-1.08],0.154183345921679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDHR1,Cadherin-related family member 1,Inverse variance weighted,19,1.1 [0.96-1.27],0.155352955404385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD160,CD160 antigen,Inverse variance weighted,24,0.87 [0.72-1.05],0.156293124339783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,0.81 [0.61-1.08],0.158050657836336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.23 [0.92-1.63],0.159052288095127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DLK1,Protein delta homolog 1,Inverse variance weighted,10,0.8 [0.58-1.09],0.159521294832281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL11,Eotaxin,Inverse variance weighted,11,0.9 [0.78-1.04],0.160129414813731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.15 [0.95-1.4],0.161260737759572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.09 [0.97-1.23],0.16278910713987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.76 [0.51-1.12],0.163190372775833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,2,1.4 [0.87-2.24],0.164425953516109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.71 [0.44-1.15],0.169174877571762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCN4,CCN family member 4,Inverse variance weighted,29,1.06 [0.97-1.15],0.17702761971367,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.13 [0.94-1.36],0.178842401176713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.58 [0.26-1.29],0.179145290590841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,1.39 [0.86-2.25],0.183015212927984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PALM2,Paralemmin-2,Inverse variance weighted,9,1.11 [0.95-1.29],0.183026403639219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,0.88 [0.73-1.06],0.189581766994398,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RGMB,RGM domain family member B,Inverse variance weighted,5,0.75 [0.49-1.15],0.189974457156237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.18 [0.92-1.51],0.190374054962015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,43,0.98 [0.95-1.01],0.192979137550234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,UNC5D,Netrin receptor UNC5D,Wald ratio,1,2 [0.7-5.74],0.194743294744084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.67 [0.37-1.23],0.196273799263275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VASN,Vasorin,Inverse variance weighted,5,0.76 [0.5-1.15],0.196716748634842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.85 [0.67-1.09],0.197597512040301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PCDH12,Protocadherin-12,Inverse variance weighted,6,1.36 [0.85-2.18],0.199688146007309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.87 [0.71-1.07],0.202075854586537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.22 [0.9-1.66],0.205945205002494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AMBP,Protein AMBP,Inverse variance weighted,5,1.16 [0.92-1.46],0.205961550256452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.79 [0.55-1.14],0.214124801260492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEPTIN8,Septin-8,Inverse variance weighted,4,0.8 [0.57-1.14],0.218520782671441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.63 [0.3-1.32],0.220468598434064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLK6,Kallikrein-6,Inverse variance weighted,2,1.37 [0.82-2.29],0.222542145517029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.12 [0.93-1.33],0.223324633643192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.08 [0.95-1.23],0.226233032749895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.04 [0.98-1.1],0.227602288139292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.61 [0.74-3.51],0.228001480835031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD99,CD99 antigen,Inverse variance weighted,4,0.83 [0.6-1.13],0.232053261958606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FBLN2,Fibulin-2,Inverse variance weighted,6,1.24 [0.87-1.78],0.237483544865889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.87 [0.68-1.1],0.241882178385396,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,0.83 [0.61-1.13],0.244729330704057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,1.19 [0.89-1.6],0.247550545110821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD83,CD83 antigen,Inverse variance weighted,14,1.12 [0.92-1.36],0.24827261013745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.73 [0.42-1.26],0.255237604926727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.09 [0.94-1.27],0.257194553926378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTH,Parathyroid hormone,Inverse variance weighted,11,1.12 [0.92-1.36],0.263805660074926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,POF1B,Protein POF1B,Inverse variance weighted,4,0.83 [0.59-1.16],0.26720405553042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.13 [0.91-1.39],0.270655765233996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.24 [0.84-1.81],0.274764725022401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,0.94 [0.84-1.05],0.277713470877414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VIT,Vitrin,Inverse variance weighted,10,1.12 [0.91-1.38],0.281556783655757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MMP13,Collagenase 3,Wald ratio,1,0.63 [0.28-1.46],0.283289427523874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.46 [0.73-2.91],0.285043732051361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.31 [0.8-2.14],0.28810523531472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.12 [0.91-1.38],0.292101833551365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.85 [0.63-1.15],0.294741409389622,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,OMD,Osteomodulin,Inverse variance weighted,15,1.09 [0.92-1.29],0.296533701130966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NRP1,Neuropilin-1,Inverse variance weighted,14,1.12 [0.9-1.4],0.299628827013595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.29 [0.8-2.07],0.300543697655826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.09 [0.92-1.29],0.301177889029076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.17 [0.86-1.6],0.302976780629306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.37 [0.75-2.48],0.303715184788907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DSG3,Desmoglein-3,Inverse variance weighted,27,1.05 [0.95-1.16],0.307465602321399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RGMA,Repulsive guidance molecule A,Inverse variance weighted,35,0.95 [0.87-1.05],0.312371574902686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.38 [0.74-2.57],0.316550275592784,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MYL3,Myosin light chain 3,Inverse variance weighted,13,0.86 [0.65-1.15],0.318622837092221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,0.97 [0.92-1.03],0.319815342145876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.82 [0.55-1.21],0.320605121262475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPARCL1,SPARC-like protein 1,Inverse variance weighted,21,0.92 [0.79-1.08],0.323990770406681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.91 [0.76-1.09],0.326525970600232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,16,0.92 [0.78-1.09],0.327127992980353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.15 [0.87-1.52],0.328746452048649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MMP3,Stromelysin-1,Inverse variance weighted,4,0.78 [0.47-1.29],0.329041369489306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.84 [0.6-1.19],0.330569732225731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL15,Interleukin-15,Inverse variance weighted,35,0.95 [0.85-1.06],0.333939883820476,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD302,CD302 antigen,Inverse variance weighted,11,1.09 [0.91-1.32],0.336918263169324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,WNT9A,Protein Wnt-9a,Wald ratio,1,1.68 [0.58-4.91],0.342184737572935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.74 [0.4-1.38],0.345210745906011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.31 [0.75-2.27],0.345339329810446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.71 [0.35-1.45],0.350397675266619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.87 [0.65-1.17],0.350476576085144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,9,1.18 [0.84-1.66],0.350632518433589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.09 [0.91-1.31],0.35318232113169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.14 [0.86-1.51],0.354782839847806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.93 [0.79-1.09],0.356404990396186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.74 [0.39-1.41],0.356648727909813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.8 [0.51-1.28],0.358902663606664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,1.31 [0.73-2.36],0.359710227743664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.97 [0.9-1.04],0.364432448502968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REN,Renin,Inverse variance weighted,8,0.86 [0.62-1.19],0.365347277760636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MMP10,Stromelysin-2,Wald ratio,1,0.64 [0.24-1.68],0.367175871243498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.05 [0.94-1.17],0.3677027355606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.97 [0.92-1.03],0.371133571230382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL19,Interleukin-19,Inverse variance weighted,10,0.95 [0.84-1.07],0.379112986265384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,OGN,Mimecan,Inverse variance weighted,37,0.96 [0.88-1.05],0.382157678526854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ANG,Angiogenin,Inverse variance weighted,8,0.86 [0.6-1.22],0.38309641456825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CX3CL1,Fractalkine,Inverse variance weighted,12,0.9 [0.7-1.15],0.38508158618293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPRR3,Small proline-rich protein 3,Inverse variance weighted,6,0.88 [0.66-1.17],0.38559265566088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CST3,Cystatin-C,Inverse variance weighted,3,1.41 [0.64-3.08],0.396358608523947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.24 [0.75-2.05],0.396821699017826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,0.79 [0.46-1.36],0.397610128843076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PI3,Elafin,Inverse variance weighted,18,1.05 [0.94-1.16],0.399883219423486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DRAXIN,Draxin,Inverse variance weighted,25,1.08 [0.9-1.29],0.400074469493661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.97 [0.9-1.05],0.405775254220901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.1 [0.88-1.38],0.408176102430678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.36 [0.65-2.84],0.411209226240958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DPT,Dermatopontin,Inverse variance weighted,4,0.82 [0.52-1.31],0.413321291716362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,1.08 [0.9-1.29],0.416114561266329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.21 [0.76-1.93],0.416727786561114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,0.92 [0.75-1.13],0.417990147647404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,1.3 [0.69-2.43],0.419025412662709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,1.12 [0.84-1.5],0.422558765374521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.9 [0.69-1.17],0.422957656084302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.16 [0.81-1.66],0.424025866106264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.08 [0.9-1.3],0.427098671064529,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHAD,Chondroadherin,Inverse variance weighted,15,0.96 [0.87-1.06],0.428824069186014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.09 [0.88-1.36],0.430315501282897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.06 [0.92-1.21],0.432836337098141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCGB1A1,Uteroglobin,Inverse variance weighted,38,1.06 [0.92-1.21],0.438314952686589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP6,Gastrotropin,Inverse variance weighted,4,1.21 [0.74-1.99],0.440340753854875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,0.91 [0.72-1.16],0.441903081531315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RETN,Resistin,Inverse variance weighted,19,0.93 [0.77-1.12],0.443973296148288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.94 [0.8-1.11],0.446661125564025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MMP7,Matrilysin,Wald ratio,1,0.87 [0.62-1.24],0.446669382611296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MB,Myoglobin,Inverse variance weighted,9,0.91 [0.7-1.17],0.4472796527738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NRP2,Neuropilin-2,Inverse variance weighted,14,1.09 [0.88-1.34],0.448016023238333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,50,0.97 [0.88-1.06],0.448562678987787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,9,0.94 [0.81-1.1],0.452117865859971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.1 [0.86-1.41],0.455346453310792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NECTIN4,Nectin-4,Inverse variance weighted,4,0.85 [0.55-1.31],0.456277410598632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Inverse variance weighted,16,1.09 [0.87-1.36],0.457557408637507,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.16 [0.78-1.74],0.457562731763748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RSPO3,R-spondin-3,Inverse variance weighted,5,0.88 [0.64-1.23],0.458565520850145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,1.07 [0.89-1.29],0.461483735529492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.24 [0.7-2.19],0.46542048046059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,35,0.97 [0.9-1.05],0.467851904351762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,XG,Glycoprotein Xg,Inverse variance weighted,2,0.65 [0.2-2.11],0.472165617823329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,1.36 [0.58-3.17],0.475948942213269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COLEC12,Collectin-12,Inverse variance weighted,3,0.82 [0.48-1.41],0.477955313512926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,0.89 [0.63-1.24],0.479620530984145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,19,0.97 [0.9-1.05],0.479694178804948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.04 [0.93-1.16],0.479818249071075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCN5,CCN family member 5,Inverse variance weighted,12,1.05 [0.92-1.19],0.479823333751689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.16 [0.77-1.74],0.48011944022841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.93 [0.76-1.14],0.48589455100548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,0.98 [0.92-1.04],0.488488965281302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.84 [0.5-1.39],0.490430980003041,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.11 [0.82-1.52],0.491301421228625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,1.4 [0.53-3.67],0.491966273896234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.11 [0.82-1.5],0.493359809086754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PRELP,Prolargin,Inverse variance weighted,5,0.84 [0.51-1.38],0.493677025797943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,1.02 [0.96-1.09],0.505475433029042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CFD,Complement factor D,Wald ratio,1,1.31 [0.59-2.94],0.507121977138503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CALB1,Calbindin,Inverse variance weighted,9,1.09 [0.84-1.42],0.509339025481958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CTSV,Cathepsin L2,Inverse variance weighted,34,1.03 [0.94-1.14],0.514633165115719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.86 [0.55-1.35],0.517029671583718,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL17C,Interleukin-17C,Inverse variance weighted,5,0.88 [0.61-1.29],0.519073336490775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDH15,Cadherin-15,Inverse variance weighted,4,0.86 [0.54-1.37],0.520583262881697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,0.72 [0.27-1.94],0.520797597968724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,1.11 [0.8-1.54],0.522169967196903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.94 [0.78-1.14],0.523383615147797,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.02 [0.95-1.11],0.523682458591024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,38,1.03 [0.94-1.13],0.528872999344328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPON1,Spondin-1,Inverse variance weighted,4,1.26 [0.62-2.57],0.530172199077489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.92 [0.7-1.2],0.531253486931608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AREG,Amphiregulin,Inverse variance weighted,5,1.11 [0.79-1.57],0.541649165513214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.94 [0.76-1.15],0.542504152867192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.34 [0.52-3.4],0.542924900306348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.79 [0.37-1.68],0.544992404610663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.09 [0.82-1.45],0.547096665622037,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHGB,Secretogranin-1,Inverse variance weighted,7,0.93 [0.74-1.17],0.548272184648361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.95 [0.81-1.12],0.548464651094819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD27,CD27 antigen,Inverse variance weighted,9,0.88 [0.57-1.35],0.550289162624944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CFC1,Cryptic protein,Inverse variance weighted,11,1.12 [0.78-1.61],0.552433982833569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.1 [0.81-1.48],0.552472187798627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.16 [0.71-1.89],0.555639238873349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,1.05 [0.89-1.24],0.555763918857479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,S100G,Protein S100-G,Inverse variance weighted,4,0.89 [0.61-1.3],0.55794054743599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.95-1.09],0.558366072391892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,1.08 [0.83-1.4],0.558571064805274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,XCL1,Lymphotactin,Inverse variance weighted,15,0.94 [0.75-1.17],0.559242372155199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.97 [0.88-1.07],0.559425336630429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.27 [0.57-2.84],0.560870850506092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,0.95 [0.78-1.14],0.562373515245177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.89 [0.6-1.33],0.572162065511435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.02 [0.94-1.11],0.578642274100351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.89 [0.58-1.36],0.583880660134612,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.93 [0.71-1.21],0.585358297437678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHGA,Chromogranin-A,Inverse variance weighted,5,0.91 [0.65-1.28],0.588117815030489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.13 [0.72-1.77],0.589914780007011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,1.11 [0.75-1.64],0.599118544641571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.95 [0.78-1.16],0.606775730738945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.91 [0.63-1.32],0.609599801062871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.03 [0.91-1.18],0.610850499441413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.21 [0.57-2.57],0.611868170469111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.12 [0.71-1.78],0.615989025937734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.87 [0.49-1.52],0.618281714135346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.85 [0.45-1.6],0.618899414403064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.91 [0.61-1.34],0.62306320787231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NXPH3,Neurexophilin-3,Inverse variance weighted,19,1.02 [0.94-1.11],0.624669552479494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.97 [0.85-1.11],0.634933357782256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.94 [0.74-1.2],0.635171613151422,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.96 [0.8-1.15],0.635973146074678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GRN,Progranulin,Inverse variance weighted,46,1.02 [0.95-1.09],0.637706896398482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.22 [0.52-2.88],0.643989994671156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PENK,Proenkephalin-A,Inverse variance weighted,15,1.05 [0.86-1.29],0.646808517173219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.17 [0.58-2.36],0.652911713353901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,1.06 [0.81-1.39],0.654452434919598,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LGALS3,Galectin-3,Inverse variance weighted,15,0.96 [0.79-1.16],0.659383432923649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.93 [0.69-1.27],0.660799775409575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.86 [0.45-1.66],0.661018003484465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.04 [0.86-1.26],0.662254269388475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.08 [0.78-1.49],0.663411205489165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCN3,CCN family member 3,Inverse variance weighted,17,1.03 [0.9-1.17],0.670867777451496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.01 [0.96-1.06],0.672562137185247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.15 [0.6-2.21],0.674507427846768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.99 [0.94-1.04],0.677228015386937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,0.95 [0.73-1.23],0.682331806487563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1.03 [0.91-1.16],0.684508397562942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.97 [0.83-1.13],0.687399682467707,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SDC1,Syndecan-1,Inverse variance weighted,12,0.96 [0.79-1.17],0.692041260719064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,1.13 [0.62-2.06],0.693126353452118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTPRR,Receptor-type tyrosine-protein phosphatase R,Wald ratio,1,0.89 [0.5-1.59],0.693735832159478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLK11,Kallikrein-11,Inverse variance weighted,13,0.96 [0.78-1.18],0.694288195768548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.92 [0.59-1.42],0.696671692613945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.04 [0.84-1.3],0.69763526212572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RTBDN,Retbindin,Inverse variance weighted,2,0.9 [0.55-1.5],0.697839337464172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.03 [0.9-1.16],0.698333306532331,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.98 [0.87-1.09],0.700585757624358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.88 [0.46-1.7],0.703289016748625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.98 [0.88-1.09],0.707168145515071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.15 [0.56-2.38],0.707538066402245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.97 [0.83-1.13],0.709193803114272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.98 [0.91-1.07],0.71226092816671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,24,0.97 [0.81-1.15],0.715584777635299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.26 [0.36-4.45],0.717853661732678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.95 [0.72-1.25],0.717874071843575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.94 [0.69-1.29],0.718172581077026,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.03 [0.86-1.24],0.722925561775992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.05 [0.81-1.36],0.725233078612734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,0.97 [0.84-1.13],0.726012454405577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NECTIN2,Nectin-2,Inverse variance weighted,3,1.12 [0.6-2.07],0.728112863711353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.94 [0.68-1.32],0.732084302209272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.05 [0.79-1.39],0.736487097268721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.99 [0.91-1.07],0.73738463376162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SBSN,Suprabasin,Inverse variance weighted,10,1.06 [0.75-1.5],0.739476705093626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.06 [0.76-1.46],0.741771527298031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,F3,Tissue factor,Inverse variance weighted,13,1.05 [0.8-1.38],0.743464039838495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.98 [0.89-1.09],0.746949486959452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,1.03 [0.85-1.25],0.749951811283864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,0.99 [0.92-1.06],0.750022592477254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.05 [0.76-1.45],0.760008300438112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.05 [0.78-1.4],0.761130487752234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.03 [0.86-1.22],0.763262990952618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.98 [0.86-1.12],0.766099684052626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.04 [0.79-1.39],0.766694974052689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.04 [0.79-1.38],0.767575314248388,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,5,1.06 [0.74-1.51],0.76792725948387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ALCAM,CD166 antigen,Inverse variance weighted,4,0.96 [0.74-1.25],0.770684550060789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PPL,Periplakin,Inverse variance weighted,2,0.93 [0.56-1.53],0.773326553380641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VCAN,Versican core protein,Inverse variance weighted,30,0.98 [0.86-1.12],0.773610512437358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PLA2G1B,Phospholipase A2,Inverse variance weighted,20,1.03 [0.86-1.23],0.774657442457167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.03 [0.84-1.26],0.77662707122685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AGRP,Agouti-related protein,Inverse variance weighted,16,1.02 [0.89-1.17],0.777956473569976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CALCA,Calcitonin,Inverse variance weighted,13,0.96 [0.7-1.31],0.778793886890089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DSG2,Desmoglein-2,Inverse variance weighted,22,0.98 [0.87-1.11],0.78310525103226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PRSS2,Trypsin-2,Inverse variance weighted,17,1.02 [0.87-1.2],0.7837169304485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.92 [0.51-1.66],0.785448199354787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.08 [0.62-1.89],0.787526798391271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.01 [0.93-1.11],0.788753350536152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.02 [0.9-1.14],0.789958862008862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.96 [0.73-1.27],0.79021381991615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.93 [0.56-1.55],0.793780916658501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.08 [0.6-1.94],0.794455837149417,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.99 [0.93-1.06],0.796668663907724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.14 [0.42-3.12],0.799889678159132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.97 [0.76-1.24],0.800075408569178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,0.93 [0.52-1.65],0.800856278765619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.02 [0.89-1.16],0.801669071329491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LGALS4,Galectin-4,Inverse variance weighted,15,1.02 [0.9-1.15],0.802459728735603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.07 [0.65-1.75],0.803295168486198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.03 [0.82-1.3],0.813202619369693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,0.93 [0.52-1.68],0.8140525086002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.98 [0.79-1.21],0.820138884563506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.08 [0.56-2.09],0.822016596876433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.95 [0.6-1.51],0.822032426318795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PALM,Paralemmin-1,Inverse variance weighted,4,0.94 [0.53-1.65],0.822872944102383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.95 [0.59-1.52],0.823281542815391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1.1 [0.46-2.64],0.824675295458079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.02 [0.85-1.23],0.824722358365604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,13,0.98 [0.82-1.18],0.825054866001652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DSC2,Desmocollin-2,Inverse variance weighted,16,1.01 [0.9-1.13],0.829080463788128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DCN,Decorin,Inverse variance weighted,2,1.08 [0.55-2.09],0.829704725995944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,6,1.04 [0.72-1.52],0.830450108041825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.95 [0.59-1.54],0.83069376225795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.04 [0.74-1.44],0.831306045075362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.96 [0.66-1.4],0.831823384161839,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.05 [0.64-1.74],0.838981638539055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BSG,Basigin,Inverse variance weighted,6,0.96 [0.66-1.4],0.840812273009236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PRSS8,Prostasin,Inverse variance weighted,14,1.02 [0.83-1.25],0.840869386933993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,1.02 [0.81-1.29],0.842340217369061,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,1.09 [0.48-2.48],0.843729881723797,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CTSL,Cathepsin L1,Inverse variance weighted,29,0.99 [0.85-1.14],0.844281499560416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,14,0.98 [0.77-1.25],0.853974775440411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.02 [0.84-1.23],0.854838731659883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPP1,Osteopontin,Inverse variance weighted,13,0.97 [0.73-1.3],0.856024103045077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.97 [0.66-1.41],0.856061869413764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CTRB1,Chymotrypsinogen B,Inverse variance weighted,19,0.98 [0.82-1.18],0.856103990858012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.02 [0.84-1.24],0.858035999962508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1.01 [0.92-1.11],0.862444978984876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,40,1.01 [0.92-1.1],0.866926822176356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK6,Serine protease inhibitor Kazal-type 6,Wald ratio,1,0.93 [0.38-2.27],0.867529544058785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.99 [0.84-1.16],0.870529312097003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.03 [0.73-1.45],0.870687384331086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GUCA2A,Guanylin,Inverse variance weighted,7,0.98 [0.76-1.26],0.875212442491833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.97 [0.63-1.48],0.881146172613305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.96 [0.57-1.62],0.885000664388385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.97 [0.68-1.39],0.8854455596437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.04 [0.62-1.73],0.886484391404112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,1.02 [0.8-1.29],0.887330861388924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,1.06 [0.46-2.45],0.888299265747812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,1.01 [0.94-1.08],0.888665434178613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SERPINB8,Serpin B8,Inverse variance weighted,29,1 [0.96-1.05],0.889707872649542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.96 [0.58-1.62],0.891336694552509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCG2,Secretogranin-2,Inverse variance weighted,2,0.97 [0.59-1.59],0.891803880895531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.98 [0.78-1.24],0.892133876680143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,THBD,Thrombomodulin,Inverse variance weighted,11,0.99 [0.86-1.14],0.893655416823002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDH3,Cadherin-3,Inverse variance weighted,10,0.98 [0.71-1.35],0.894530019387843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1 [0.95-1.06],0.897158913835891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,1.03 [0.65-1.64],0.900640427848755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.01 [0.81-1.27],0.901142345744795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.99 [0.78-1.25],0.904568012361281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1 [0.94-1.07],0.909494829237362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.01 [0.82-1.25],0.911652134766594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.99 [0.75-1.29],0.912240750953614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Wald ratio,1,1.05 [0.43-2.54],0.912826338784564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1 [0.92-1.08],0.916580023495824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,APOA4,Apolipoprotein A-IV,Inverse variance weighted,4,0.98 [0.61-1.57],0.917676683939905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLK4,Kallikrein-4,Inverse variance weighted,5,1.02 [0.63-1.65],0.923162729499782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.03 [0.58-1.83],0.923769805439758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CSTB,Cystatin-B,Inverse variance weighted,23,1 [0.93-1.08],0.926358662051415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.01 [0.86-1.19],0.930462106584769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.98 [0.61-1.57],0.932451208423603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.01 [0.83-1.22],0.933771831316769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.01 [0.81-1.26],0.936817632272356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LAYN,Layilin,Inverse variance weighted,3,1.02 [0.6-1.73],0.937268637970843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.02 [0.67-1.54],0.942065096788014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.99 [0.85-1.17],0.942182779576965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLK8,Kallikrein-8,Inverse variance weighted,5,0.99 [0.7-1.4],0.947808269298633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.01 [0.81-1.25],0.949376054343458,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.98 [0.49-1.97],0.95315163843652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.99 [0.69-1.42],0.953189513045054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,1 [0.88-1.15],0.954931075210676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,0.99 [0.8-1.24],0.956879005306214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.98 [0.47-2.03],0.956896939893038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.01 [0.54-1.91],0.964370226095658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.99 [0.56-1.76],0.965255379531634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDH1,Cadherin-1,Inverse variance weighted,16,1 [0.89-1.12],0.973708329581834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPON2,Spondin-2,Inverse variance weighted,3,1.01 [0.6-1.69],0.973816626477045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.01 [0.65-1.57],0.974503962183312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PGA4,Pepsin A-4,Inverse variance weighted,7,0.99 [0.68-1.45],0.976845620397264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1 [0.79-1.28],0.977877297985001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FAM3D,Protein FAM3D,Inverse variance weighted,38,1 [0.92-1.1],0.979361201073826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1 [0.65-1.52],0.982091325503789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,OCLN,Occludin,Inverse variance weighted,2,0.99 [0.58-1.7],0.982263451722421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1 [0.69-1.43],0.983604275534251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,1 [0.79-1.27],0.985198914592187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GPC1,Glypican-1,Inverse variance weighted,28,1 [0.9-1.1],0.985670722825297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1 [0.64-1.55],0.989826311039703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TFF3,Trefoil factor 3,Inverse variance weighted,10,1 [0.83-1.21],0.990702707907419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1 [0.78-1.29],0.992519276883667,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,1 [0.81-1.23],0.997355730573006,trans
